Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
(NQ: )
N/A   UNCHANGED
Last Price  /  Updated:   /  Add to My Watchlist      
View: Quote News
Press releases about
 
< Previous 1 2 Next >
Nastech to Release Third Quarter Financial Results and Host Webcast on Monday, October 29, 2007
October 22, 2007
from PR Newswire
SCOLR Pharma, Inc. Announces the Addition of Jeff Reich, M.D. and Greg Weaver to its Board of Directors
October 08, 2007
from Business Wire News Releases
Nastech Pharmaceutical Company Announces the Jeffrey Wenig Memorial Award for Outstanding Achievement in Drug Delivery
October 05, 2007
from PR Newswire
Nastech Pharmaceutical Company Announces Promotion of Rick Costantino, Ph.D., to Chief Scientific Officer of Delivery
October 04, 2007
from PR Newswire
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for PYY3-36 Nasal Spray to Treat Obesity
October 01, 2007
from PR Newswire
Nastech to Host 2007 Analyst and Institutional Investor Day
September 26, 2007
from PR Newswire
Nastech Pharmaceutical Company Announces Initiation of Phase 2 Clinical Trial for Insulin Nasal Spray to Treat Diabetes
September 26, 2007
- Rapid-Acting, Non-Invasive Nasal Spray Dosage form is Patient Friendly and Avoids Potential Safety Concerns of Pulmonary Delivery - Read More
from PR Newswire
Nastech to Present at UBS Global Life Sciences Conference
September 20, 2007
from PR Newswire
Nastech Announces Second Quarter 2007 Financial Results
August 08, 2007
from PR Newswire
Nastech Pharmaceutical Company to Host Webinar on its Strategy for Development of RNAi Therapeutics for Treatment of Influenza
August 06, 2007
Presented by Steven Quay, M.D., Ph.D., Chairman, President and CEO of Nastech, and Michael Templin, Ph.D., Director of Pharmacology and Toxicology Read More
from PR Newswire
Nastech to Release Second Quarter Financial Results and Host Webcast on Wednesday, August 8, 2007
August 01, 2007
from PR Newswire
Nastech Pharmaceutical Company Announces Issuance of Patents for Parathyroid Hormone Nasal Spray for Osteoporosis and PYY Nasal Spray for Obesity
July 17, 2007
from PR Newswire
Nastech Announces Issuance of a U.S. Patent for Nascobal(R) Nasal Spray
June 12, 2007
Triggers $2 Million Milestone Payment from QOL Medical Read More
from PR Newswire
Talyst Names Greg Weaver as Chief Financial Officer
June 08, 2007
from Business Wire News Releases
Nastech to Present at Needham & Company Biotechnology & Medical Technology Conference
June 07, 2007
from PR Newswire
Nastech to Present at Friedman Billings Ramsey Growth Conference
May 25, 2007
from PR Newswire
Nastech Announces First Quarter 2007 Financial Results
May 07, 2007
from PR Newswire
Nastech to Present at Acumen BioFin Rodman & Renshaw Global Healthcare Conference
May 03, 2007
from PR Newswire
Nastech to Present at UBS Global Generic and Specialty Pharmaceuticals Conference
May 01, 2007
from PR Newswire
Nastech to Release First Quarter Financial Results and Host Webcast on Monday, May 7, 2007
April 26, 2007
from PR Newswire
(OTC: RCAU) Issues Stock Dividend
April 13, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. Read More
from Marketwired News Releases
(OTC: MNCL) in Negotiations for Marketing and Distribution Rights of Its Products in Spain and Portugal
March 19, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. Read More
from Marketwired News Releases
(OTC: MNCL) Rated 'Speculative Buy,' Target Price $0.13 by Beacon Equity Research
March 19, 2007
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit. Read More
from Marketwired News Releases
Nastech to Present at Invest Northwest Investor and CEO Forum
March 16, 2007
from PR Newswire
Nastech Announces Fourth Quarter and Full Year 2006 Financial Results
March 07, 2007
from PR Newswire
Nastech to Release Fourth Quarter and Full Year 2006 Financial Results and Host Webcast on Wednesday, March 7, 2007
February 23, 2007
from PR Newswire
Nastech to Present at BIO CEO & Investor Conference
February 07, 2007
from PR Newswire
Nastech Announces Pricing of Common Stock Offering
January 18, 2007
from PR Newswire
Fifty-Seven Life Science Companies Selected to Present at Invest Northwest(C) 2007
January 04, 2007
Invest Northwest(C) to Feature Innovative Pacific Northwest Biotechnology and Medical Device Firms Read More
from PR Newswire
Nastech Reports Positive PYY Nasal Spray Clinical Trial Data and Will Advance Obesity Clinical Program in 2007
December 21, 2006
Trial Demonstrates Both Intravenous and PYY Nasal Spray Produce Satiety and Calorie Reduction Read More
from PR Newswire
< Previous 1 2 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here